Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of GW685698X (Fluticasone Furoate) Nasal Spray in Pediatric Perennial Allergic Rhinitis
NCT00108914Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 3 trial of fluticasone in perennial allergic rhinitis (PAR), sponsored by GSK. Started Feb 2005; status: completed.
02
Drugs
fluticasone
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00108914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108914.